511 results
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
breast cancer patients
I/C
long non-coding RNA (lncRNA) HOTAIR, poor survival rates
O
poor disease-free survival (DFS), poor distant metastatic-free survival (MFS)
P
patients with cancer
I/C
poor sleep quality, healthy controls
O
higher risk for poor sleep quality
P
poor responders
I/C
transdermal testosterone gel, no intervention
O
higher live birth rate, higher clinical pregnancy rate, increased number of cumulus-oocyte complexes retrieved, fewer days to complete ovarian stimulation, lower total dose of gonadotrophins, lower cancellation rate due to poor ovarian response, thicker endometrium
P
patients with hepatocellular carcinoma (HCC)
I/C
serum neutrophil-lymphocyte ratio (NLR) levels, poor prognosis or recurrence of HCC
O
high baseline NLR was significantly associated with poor prognosis or recurrence of HCC
P
poor responders in IVF treatment
I/C
mild ovarian stimulation with genuine low-dose gonadotrophin (≤150 IU daily) alone or in combination with oral medications, conventional-dose (>150 IU/day) IVF for poor responders
O
live birth rate, ongoing pregnancy rate, cycle cancellation rates, number and proportion of high-grade embryos, gonadotrophin use and cost
P
schizophrenia patients
I/C
neurocognitive functioning, social cognition, positive symptoms, negative symptoms, disorganization, depression
O
poor insight
P
biliary tract cancer (BTC) patients
I/C
tumor budding assessment, patients with vs. without tumor budding
O
poor survival outcomes, poor OS, poor DFS
P
2,177 patients with OS and 477 patients with DFS/PFS data
I/C
FOXD2-AS1 expression, high expression of FOXD2-AS1 vs. low expression
O
poor OS, poor DFS, poor PFS
P
aneurysmal subarachnoid hemorrhage (aSAH)
I/C
neutrophil to lymphocyte ratio (NLR)
O
poor outcome